GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anti-Microbial Savior BioteQ Co Ltd (ROCO:6864) » Definitions » EV-to-FCF

Anti-Microbialvior BioteQ Co (ROCO:6864) EV-to-FCF : -13.02 (As of Jun. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Anti-Microbialvior BioteQ Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Anti-Microbialvior BioteQ Co's Enterprise Value is NT$648.16 Mil. Anti-Microbialvior BioteQ Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-49.78 Mil. Therefore, Anti-Microbialvior BioteQ Co's EV-to-FCF for today is -13.02.

The historical rank and industry rank for Anti-Microbialvior BioteQ Co's EV-to-FCF or its related term are showing as below:

ROCO:6864' s EV-to-FCF Range Over the Past 10 Years
Min: -36.87   Med: -15.24   Max: -10.91
Current: -13.08

During the past 6 years, the highest EV-to-FCF of Anti-Microbialvior BioteQ Co was -10.91. The lowest was -36.87. And the median was -15.24.

ROCO:6864's EV-to-FCF is ranked worse than
100% of 379 companies
in the Biotechnology industry
Industry Median: 8.31 vs ROCO:6864: -13.08

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-05), Anti-Microbialvior BioteQ Co's stock price is NT$25.90. Anti-Microbialvior BioteQ Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-2.068. Therefore, Anti-Microbialvior BioteQ Co's PE Ratio for today is At Loss.


Anti-Microbialvior BioteQ Co EV-to-FCF Historical Data

The historical data trend for Anti-Microbialvior BioteQ Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anti-Microbialvior BioteQ Co EV-to-FCF Chart

Anti-Microbialvior BioteQ Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial - - -54.88 -16.61 -11.11

Anti-Microbialvior BioteQ Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only -54.88 - -16.61 - -11.11

Competitive Comparison of Anti-Microbialvior BioteQ Co's EV-to-FCF

For the Biotechnology subindustry, Anti-Microbialvior BioteQ Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anti-Microbialvior BioteQ Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anti-Microbialvior BioteQ Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Anti-Microbialvior BioteQ Co's EV-to-FCF falls into.



Anti-Microbialvior BioteQ Co EV-to-FCF Calculation

Anti-Microbialvior BioteQ Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=648.156/-49.779
=-13.02

Anti-Microbialvior BioteQ Co's current Enterprise Value is NT$648.16 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Anti-Microbialvior BioteQ Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-49.78 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anti-Microbialvior BioteQ Co  (ROCO:6864) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Anti-Microbialvior BioteQ Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=25.90/-2.068
=At Loss

Anti-Microbialvior BioteQ Co's share price for today is NT$25.90.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Anti-Microbialvior BioteQ Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-2.068.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Anti-Microbialvior BioteQ Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Anti-Microbialvior BioteQ Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Anti-Microbialvior BioteQ Co (ROCO:6864) Business Description

Traded in Other Exchanges
N/A
Address
Sec.1, Huandong Road, 1 Floor, No. 2, Ln. 31, Xinshi District, Tainan, TWN, 741
Anti-Microbial Savior BioteQ Co Ltd is engaged in drug research and development as well as development and technology patenting of medical fungi.

Anti-Microbialvior BioteQ Co (ROCO:6864) Headlines

No Headlines